Cell&Soft & Enterosys combined expertise’s

CRO dermatologie

Enterosys provides in vitro models closer to physiology for dermo cosmetic applications.

Numerous scientific studies have demonstrated the key role of NO and H2O2 in the regulation of skin homeostasis. Released in small quantities by skin barrier cells, these mediators are involved in processes that are essential for maintaining skin health. However, when the skin is stressed (oxidizing agents, aging, exacerbated inflammation, pollution…), the exacerbated release of NO and H2O2 leads to alterations in vital biological processes, which affect skin balance.

Enterosys is a biotechnology company developing high quality preclinical evaluation services. Part of our activities concerns dermo cosmetic studies (evaluation of safety and efficacy in vitro). We combine our technologies and know-how to develop an innovative method based on amperometry for the ultrasensitive detection of reactive oxygen species (NO and H2O2) in real time from keratinocytes, which can be used to predict the antioxidant capacity of new dermo cosmetic compounds.

Recently, Enterosys has developed a strong partnership with Cell&Soft, a company specialized in the development of in vitro matrices reproducing the mechanical characteristics of in vivo. To be relevant, a good in vitro culture system must not only allow for the survival and growth of cells but must also closely resemble the natural microenvironment.

In vivo, cells are organized in various soft and elastic tissues with specific physical properties. Because of their distinct composition and function, each tissue/organ has its own rigidity, which can evolve according to physiological and/or pathological modifications (aging, scarring, fibrosis…). This rigidity plays a major role in cellular responses, influencing many biological processes. The plastic culture systems commonly used in laboratories have a rigidity a million times higher than almost all the organs that constitute us! The average value of the skin is between 4.5 kPa and 8 kPa and depends mainly on the mechanical properties of the dermis which gives it elasticity and resistance to stretching.

In addition, the cells that make up the different layers of the skin are very mechanically sensitive. Keratinocytes can detect a wide range of biophysical properties, including the stiffness of the extracellular matrix. The mechano-sensitivity[JCM1]  of keratinocytes regulates many cellular functions such as proliferation, differentiation, and migration.

The development of alternative approaches for safety and efficacy testing that avoid animal exploitation is a global need. Thus, Cell&Soft is striving to develop in vitro matrices that mimic the specific mechanical characteristics of in vivo, such as those of the skin, to provide a platform that is broadly suitable for skin cell models and can be reliably monitored in real time and in a high-throughput approach.

Experimental data have shown that the use of Skin Mecachips™ microplates allows keratinocytes to organize into more physiological structures. In addition, amperometric analysis demonstrated the advantage of Skin Mecachips™ over standard techniques to improve the accuracy of amperometric measurements for both models (NO and H2O2), increasing sensitivity while reducing intragroup variability.

Now, Enterosys offers this complementary expertise to combine Skin Mecachips™ microplates in their dedicated ROS assays for skin studies.

Source : https://www.skinobs.com/news/conseils-d-expert/dossiers-thematiques/des-tests-defficacite-in-vitro-plus-proches-de-la-physiologie-enterosys-integre-desormais-les-skin-mecachips-dans-ses-tests-reactive-oxygen-species-ros/


 [JCM1]le mot est coupé avec un tiret je pense..

Research

Categorie

Archives

Enterosys will attend NutrEvent 2022 in Nantes

NutrEvent is the event dedicated to innovation in Food, Feed, Nutrition and Health. This year, NutrEvent is back for its 8th edition in hybrid format. Enterosys will be present with a validated, complete and innovative offer of in vitro and in vivo preclinical...

Enterosys welcomes its new business developer

Pauline Caseilles have joined the Enterosys team this month as Scientific Business Developer. Its aim is to publicize Enterosys' service offerings. Pauline obtained a Master’s degree in Health Biology and a Specialized Mastere in Marketing and Sales also in the field...

Antioxidant and anti-inflammatory properties of maternal milk

The high hydrostatic pressure processing of donor milk may better protect preterm infants from gut and liver pathologies compared to Holder pasteurization, which is currently used in most human milk banks. Preterm infants are highly susceptible to oxidative stress due...

Targeting our second brain using prebiotics

The discovery of intestinal actors, such as enterosynes, able to modulate the ENS-induced duodenal contraction is an innovative approach. Among all the intestinal factors, the understanding of the role of gut microbes in controlling glycaemia remains a major target....

Commercial H/F – Biotechnologie

What we will accomplish together Pursue your career with a pure player in preclinical testing and accompany us in our growth! We need your scientific knowledge and your commercial appetite to build the commercial division! We are waiting for you at a key moment of our...